Saxagliptin
In the US, Saxagliptin (saxagliptin systemic) is a member of the drug class dipeptidyl peptidase 4 inhibitors and is used to treat Diabetes, Type 2.
US matches:
- Saxagliptin
- Saxagliptin/metformin extended-release tablets
- Saxagliptin and metformin
- Saxagliptin Hydrochloride
- Saxagliptin/Metformin Hydrochloride
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
A10BH03
CAS registry number (Chemical Abstracts Service)
0361442-04-8
Chemical Formula
C18-H25-N3-O2
Molecular Weight
315
Therapeutic Category
Oral antidiabetic agent: Dipeptidyl peptidase-4 (DPP-4) inhibitor, gliptin
Chemical Names
(1S,3S,5S)-2-[(2S)-Amino(3-hydroxytricyclo[3.3.1.1³,⁷]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]-hexane-3-carbonitrile (USAN)
(1S,3S,5S)-2-{(2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrile (WHO)
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-amino(3-hydroxytricyclo[3.3.1.1³,⁷]dec-1-yl)acetyl]-, (1S,3S,5S)- (USAN)
Foreign Names
- Saxagliptinum (Latin)
- Saxagliptin (German)
- Saxagliptine (French)
- Saxagliptina (Spanish)
Generic Names
- Saxagliptin (OS: USAN, BAN)
- BMS 477118 (IS)
- OPC-262 (IS)
- UNII-8I7IO46IVQ (IS)
- Saxagliptin Hydrochloride (OS: BANM)
- UNII-Z8J84YIX6L (IS)
Brand Names
- Onglyza
Bristol-Myers Squibb, Italy; Bristol-Myers Squibb, Norway - Kombiglyze XR (Saxagliptin and Metformin)
Bristol-Myers Squibb, United States - Onglyza
Bristol-Myers Squibb, Netherlands; Bristol-Myers Squibb, Taiwan; Bristol-Myers Squibb/AstraZeneca, Germany; PharmaSwiss, Croatia (Hrvatska); AstraZeneca, Switzerland; AstraZeneca, Finland; AstraZeneca, United Kingdom; AstraZeneca, Lithuania; AstraZeneca, Mexico; AstraZeneca, Philippines; Bristol Myers Squibb, Spain; Bristol Myers Squibb, Latvia; Bristol-Myers Squibb, Austria; Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, Chile; Bristol-Myers Squibb, France; Bristol-Myers Squibb, United Kingdom; Bristol-Myers Squibb, Greece; Bristol-Myers Squibb, Lithuania; Bristol-Myers Squibb, Sweden; Bristol-Myers Squibb, Slovenia; Bristol-Myers Squibb, United States
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
